Eczema Vaccination Study

We know these are challenging times and venturing out can be especially stressful. We want you to know that at CRCC we have implemented every safety measure possible to keep you safe and prevent the spread of Covid-19. Patient areas are continually disinfected, social distancing is enforced in our lobby, and all staff wear masks/gloves throughout the day. If you arrive for your appointment and wish to wear a mask, we will provide one for you as well.

About Atopic Dermatitis

Eczema/Atopic Dermatitis is a complex disease that is determined by genetic, environmental, and immunologic factors. It is one of the most common chronic medical diseases that is characterized by redness, itching, thickening of the skin and crusted areas. Flares are frequently triggered by exposure to environmental factors, irritants, and allergens. Patients may have a high disease burden and their life quality is significantly affected. 

About the Study

This study will assess immunization response in adult and adolescent subjects with moderate-to-severe eczema.

Am I Eligible?

  • Chronic AD diagnosed for at least 2 years
  • You can cover 10 areas of your body with your palm of the affected area

What Should I Expect?

  • 7 office visits over a 24 week period.
  • Nemolizumab in combination with vaccinations

Other Information 

  • Compensation may be available for time/travel


If you are interested in participating in one of these studies, please provide your contact information below. If you are a qualified candidate, a representative from our research department will be in touch with you.

Volunteer for this study!

  • This field is for validation purposes and should be left unchanged.